tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

207 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -2.16, suggesting Keros Therapeutics is a Buy.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 45.80, while Keros Therapeutics’s (KROS) share price is $41.68, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 49.69, while Keros Therapeutics’s (KROS) share price is $41.68, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Jul 08, 2024, 10:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.71
41.38
41.78
42.45
42.84
43.51
43.91
Fibonacci
41.38
41.79
42.04
42.45
42.85
43.10
43.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Jul 08, 2024, 10:22 PM
Period
Simple
Exponential
MA5
43.33Sell
43.13Sell
MA10
44.59Sell
44.19Sell
MA20
46.12Sell
45.80Sell
MA50
50.51Sell
49.69Sell
MA100
57.02Sell
51.49Sell
MA200
47.22Sell
46.35Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 44.19, while Keros Therapeutics’s (KROS) share price is $41.68, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 51.49, while Keros Therapeutics’s (KROS) share price is $41.68, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $41.68 and Keros Therapeutics’s (KROS) 50-day simple moving average is 50.51, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $41.68 and Keros Therapeutics’s (KROS) 100-day simple moving average is 57.02, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $41.68 and Keros Therapeutics’s (KROS) 200-day simple moving average is 47.22, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Jul 08, 2024, 10:22 PM
Name
Value
Implied Action
RSI (14)
29.08
Buy
STOCH (9,6)
9.75
Buy
STOCHRSI (14)
6.68
Buy
MACD (12,26)
-2.16
Buy
ADX (14)
33.20
Neutral
Williams %R
-86.80
Buy
CCI (14)
-155.47
Buy
ATR (14)
2.01
-
Ultimate Oscillator
45.19
Neutral
ROC
-14.73
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 29.08, creating a Buy signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 33.20, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -155.47, creating a Buy signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -14.73, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 29.08, which suggests KROS is a Buy.
      What is KROS’s MACD?
      KROS’s MACD is -2.16, which suggests KROS is a Buy.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 43.33, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 46.12, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 50.51, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 47.22, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -86.80, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -155.47, which suggests KROS is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis